India to Hungary: Bleomycin Export Trade Route

The India to Hungary Bleomycin corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $336.2K USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's bleomycin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $42.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with bleomycin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #8 among India's top bleomycin export destinations globally.

On the import side, key buyers of Indian bleomycin in Hungary include E P H K, PHARMACENTER HUNGARY KFT. , PHARMACENTER HUNGARY LTD and 3 others. E P H K is the single largest importer with 2 shipments valued at $124.9K USD.

India's bleomycin exports to Hungary are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Hungary benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $42.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as bleomycin for inj usp e.vl cont.bleomyci and bleomycin for injection 15 iu bleomycin venus pharma b no x5cbl012a mfg dt 03 2025 exp dt 02 2027, suggesting that buyers in Hungary tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, E P H K is the largest importer with 2 shipments worth $124.9K USD — representing 37% of all bleomycin imports from India on this route. A total of 6 buyers are active on this corridor.